pyridostigmine bromide has been researched along with Growth Disorders in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 13 (72.22) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donaubauer, J; Keller, E; Kiess, W; Kratzsch, J; Nowak, T; Steinkamp, H; Willgerodt, H | 1 |
| Andersen, M; Fisker, S; Ørskov, H | 1 |
| Boghen, MF; Camanni, F; Cappa, M; Dammacco, F; Ferrari, C; Ghigo, E; Giordano, G; Loche, S; Minuto, F; Mucci, M | 1 |
| Bellone, J; Benedetti, S; Borrelli, P; Cappa, M; Carta, D; Ghigo, E; Grossi, A; Loche, S | 1 |
| Andò, S; Brancati, C; Bria, M; Caracciolo, M; DeLuca, G; Giorno, A; Lanzino, M; Maggiolini, M; Marsico, S; Salerno, M | 1 |
| Cappa, M; Greco, M; Perruzza, I; Rizzoni, G | 1 |
| Bettio, D; De Medici, C; Grugni, G; Guzzaloni, G; Morabito, F; Moro, D | 1 |
| Grugni, G; Guzzaloni, G; Morabito, F | 1 |
| Giambi, C; Giuliano, S; Pallotti, S | 1 |
| Arvat, E; Benso, L; Cella, SG; Corda, R; Ghigo, E; Loche, S; Müller, EE; Pintor, C; Vannelli, S; Vista, N | 1 |
| Arvat, E; Bellone, J; Boffano, GM; Cappa, M; De Sanctis, C; Ghigo, E; Imperiale, E; Loche, S; Mazza, E; Valetto, MR | 1 |
| Camanni, F; Cella, SG; Ghigo, E; Locatelli, V; Loche, S; Müller, EE; Pintor, C | 1 |
| Borrelli, P; Cappa, M; Cella, SG; Faedda, A; Loche, S; Müller, EE; Pintor, C; Salvatori, R | 1 |
| Besser, GM; Davies, SC; Froud, AL; Kirk, JM; Ross, RJ; Savage, MO; Trainer, PJ | 1 |
| Arvat, E; Barreca, A; Bellone, J; Boffano, GM; Chiabotto, P; Ghigo, E; Goffi, S; Imperiale, E; Mazza, E; Procopio, M | 1 |
| Arvat, E; Bellone, J; Camanni, F; Ghigo, E; Imperiale, E; Mazza, E; Procopio, M | 1 |
| Camanni, F; Ghigo, E; Goffi, S; Imperiale, E; Mazza, E; Müller, EE; Procopio, M | 1 |
| Bertagna, A; Camanni, F; Ghigo, E; Imperiale, E; Massara, F; Mazza, E; Molinatti, P | 1 |
3 review(s) available for pyridostigmine bromide and Growth Disorders
| Article | Year |
|---|---|
Diagnosis of growth hormone deficiency.
Topics: Adult; Arginine; Growth Disorders; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Immunoassay; Insulin; Oligopeptides; Pituitary Diseases; Pyridostigmine Bromide | 2005 |
Involvement of brain catecholamines and acetylcholine in growth hormone deficiency states. Pathophysiological, diagnostic and therapeutic implications.
Topics: Acetylcholine; Brain Chemistry; Catecholamines; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Levodopa; Parasympatholytics; Pyridostigmine Bromide | 1991 |
Neuroactive drugs in growth disorders.
Topics: Bromocriptine; Central Nervous System; Child; Clonidine; False Negative Reactions; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Levodopa; Pyridostigmine Bromide | 1990 |
6 trial(s) available for pyridostigmine bromide and Growth Disorders
| Article | Year |
|---|---|
GH secretion in thalassemia patients with short stature.
Topics: Adolescent; Age Determination by Skeleton; Arginine; Body Height; Body Mass Index; Child; Female; Growth Disorders; Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Parasympathomimetics; Pyridostigmine Bromide; Thalassemia | 1995 |
Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen in prepubertal and early pubertal short children.
Topics: Adolescent; Area Under Curve; Arginine; Child; Drug Interactions; Estrogens; Female; Growth Disorders; Growth Hormone-Releasing Hormone; Growth Substances; Human Growth Hormone; Humans; Male; Oligopeptides; Puberty; Pyridostigmine Bromide | 1998 |
Evidence for involvement of endogenous somatostatin in the galanin-induced growth hormone secretion in children.
Topics: Adolescent; Child; Drug Synergism; Female; Galanin; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Peptides; Pyridostigmine Bromide; Randomized Controlled Trials as Topic; Somatostatin | 1990 |
The growth hormone response to pyridostigmine plus growth hormone releasing hormone is not influenced by pubertal maturation.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Drug Synergism; Female; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Puberty; Pyridostigmine Bromide | 1991 |
Pyridostigmine fails to increase either spontaneous or GHRH-stimulated GH secretion during day or night in growth hormone-insufficient children.
Topics: Abdominal Pain; Child; Computers; Drug Therapy, Combination; Female; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Pyridostigmine Bromide; Single-Blind Method | 1991 |
Growth hormone responses to pyridostigmine in normal adults and in normal and short children.
Topics: Adolescent; Adult; Child; Female; Growth Disorders; Growth Hormone; Humans; Insulin; Male; Pyridostigmine Bromide | 1987 |
9 other study(ies) available for pyridostigmine bromide and Growth Disorders
| Article | Year |
|---|---|
Re-assessment of growth hormone secretion in young adult patients with childhood-onset growth hormone deficiency.
Topics: Adolescent; Adult; Age of Onset; Arginine; Case-Control Studies; Cholinesterase Inhibitors; Drug Administration Schedule; Female; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Hormone Replacement Therapy; Humans; Insulin; Male; Pituitary Gland; Predictive Value of Tests; Pyridostigmine Bromide; ROC Curve; Sensitivity and Specificity; Statistics, Nonparametric; Stimulation, Chemical | 2003 |
Somatotropic function in short stature: evaluation by integrated auxological and hormonal indices in 214 children. The Italian Collaborative Group of Neuroendocrinology.
Topics: Adolescent; Body Height; Body Mass Index; Child; Child, Preschool; Female; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin-Like Growth Factor I; Italy; Male; Puberty; Pyridostigmine Bromide | 1993 |
Growth hormone (GH) response to combined pyridostigmine and GH-releasing hormone administration in patients with Prader-Labhard-Willi syndrome.
Topics: Adolescent; Adult; Child; Drug Therapy, Combination; Female; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin-Like Growth Factor I; Male; Obesity; Prader-Willi Syndrome; Pyridostigmine Bromide | 1993 |
Can provocative growth hormone testing predict the response to recombinant human growth hormone (rhGH) treatment?
Topics: Adolescent; Child; Female; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Peptide Fragments; Predictive Value of Tests; Pyridostigmine Bromide; Renal Dialysis; Treatment Outcome | 1996 |
Reduced growth hormone (GH) responsiveness to combined GH-releasing hormone and pyridostigmine administration in the Prader-Willi syndrome.
Topics: Adolescent; Adult; Child; Cholinesterase Inhibitors; Female; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin-Like Growth Factor I; Male; Obesity; Prader-Willi Syndrome; Pyridostigmine Bromide | 1998 |
[Growth disorders in Down's syndrome: growth hormone treatment].
Topics: Adult; Blood Glucose; Body Height; Down Syndrome; Drug Evaluation; Female; Follow-Up Studies; Glycated Hemoglobin; Growth Disorders; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Levodopa; Male; Pyridostigmine Bromide; Thyroid Hormones; Treatment Outcome | 2002 |
Pyridostigmine potentiates L-dopa- but not arginine- and galanin-induced growth hormone secretion in children.
Topics: Adolescent; Arginine; Child; Drug Synergism; Drug Therapy, Combination; Female; Galanin; Growth Disorders; Growth Hormone; Humans; Levodopa; Male; Neuropeptides; Peptides; Pyridostigmine Bromide | 1990 |
A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
Topics: Administration, Oral; Adolescent; Body Height; Child; Child, Preschool; Drug Therapy, Combination; Female; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Infusions, Intravenous; Male; Pituitary Gland; Pyridostigmine Bromide | 1990 |
Cholinergic enhancement of pyridostigmine potentiates spontaneous diurnal but not nocturnal growth hormone secretion in short children.
Topics: Adolescent; Child; Circadian Rhythm; Female; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Pyridostigmine Bromide | 1989 |